In most of the lawsuits, courts have entered preliminary injunction orders that include statements like the following: Use of Novo Nordisks registered trademarks OZEMPIC, WEGOVY, and/or RYBELSUS, in connection with compounded drugs purporting to contain semaglutide or in connection with the advertising, marketing, sale, or promotion of such drugs is likely to cause confusion and infringe Novo Nordisks trademark rights
Research shows that GLP-1 medications such as semaglutide show promise for better kidney function, reduced inflammation throughout the body, and a healthier heart, says Kushner
Essential vitamins and minerals come from food
Commercial plans more often cover GLP-1s for type 2 diabetes than for obesity alone, often requiring prior authorizations
Severe, persistent stomach pain needs urgent medical attention
Recently, plant-derived products have also emerged as treatment options in IBS-D